Satsuma Pharmaceuticals, Inc.
STSA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10 | -$23 | -$15 | -$16 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $2 | $2 | $1 |
| Change in WC | -$2 | -$2 | -$0 | $3 |
| Other Non-Cash | -$0 | $12 | -$0 | $0 |
| Operating Cash Flow | -$11 | -$12 | -$13 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1 | -$22 | -$2 | -$22 |
| Inv. Sales/Matur. | $16 | $11 | $22 | $37 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $14 | -$12 | $21 | $15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$10 | $10 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $10 | -$0 |
| Financing Cash Flow | $0 | $0 | $10 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3 | -$24 | $17 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $41 | $24 | $21 |
| End Cash | $20 | $16 | $41 | $24 |
| Free Cash Flow | -$11 | -$12 | -$13 | -$12 |